Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay
- 1 May 2021
- journal article
- letter
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 27 (5) , 808-810
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2Annals of Internal Medicine, 2020
- Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological resultsClinical Microbiology and Infection, 2020
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessmentNature Communications, 2020
- Antibody tests for identification of current and past infection with SARS-CoV-2Cochrane Database of Systematic Reviews, 2020
- Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2Annals of Internal Medicine, 2020
- Laboratory Diagnosis of COVID-19: Current Issues and ChallengesJournal of Clinical Microbiology, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases, 2020
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2020